Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
- 专利权人:
- AstraZeneca AB
- 发明人:
- Rango Dietrich,Klaus Eistetter,Hartmut Ney
- 申请号：
- US13874065
- 公开号：
- US09468598B2
- 申请日:
- 2013.04.30
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- DOSAGE FORM CONTAINING PDE 4 INHIBITOR AS ACTIVE INGREDIENT
- צורת מינון לנתינה דרך הפה של מעכב pde4
- צורת מינון לנתינה דרך הפה של מעכב pde4 בעל מסיסות קלה
- Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
- ORAL DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINYLPYRROLIDON AS EXCIPIENT
